These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ideal and reality of neuroleptic relapse prevention. Kissling W Br J Psychiatry Suppl; 1992 Oct; (18):133-9. PubMed ID: 1356363 [No Abstract] [Full Text] [Related]
6. The handwriting test as an aid to neuroleptic dosage. Küstner U; Müller-Oerlinghausen B Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S34-41. PubMed ID: 2878893 [No Abstract] [Full Text] [Related]
7. [Neuroleptic non-response due to self-induced hyperosmolar diarrhea]. Metzger W; Steinert T Psychiatr Prax; 1997 Jan; 24(1):45-6. PubMed ID: 9132786 [No Abstract] [Full Text] [Related]
9. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics]. Costentin J Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181 [No Abstract] [Full Text] [Related]
10. [Neuroleptic large dose therapy of schizophrenias]. Ungvári G; Pethö B Psychiatr Neurol Med Psychol (Leipz); 1981 Apr; 33(4):230-6. PubMed ID: 6114506 [TBL] [Abstract][Full Text] [Related]
11. Routinely measuring schizophrenia treatment quality--shortcomings with medical records. Young AS Med Care; 2007 Jan; 45(1):104; author reply 104-5. PubMed ID: 17279029 [No Abstract] [Full Text] [Related]
12. [Simplification and optimization in drug therapy for patients with schizophrenia--knowledge and techniques in drug switching]. Takeda T Seishin Shinkeigaku Zasshi; 2006; 108(6):624-30. PubMed ID: 16910541 [No Abstract] [Full Text] [Related]
13. The future of neuroleptic psychopharmacology. Ortiz A; Gershon S J Clin Psychiatry; 1986 May; 47 Suppl():3-11. PubMed ID: 2871013 [TBL] [Abstract][Full Text] [Related]
14. Neuroleptic prescription for Chinese schizophrenics in Hong Kong. Chiu H; Lee S; Leung CM; Wing YK Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673 [TBL] [Abstract][Full Text] [Related]
16. [Discontinuation of neuroleptic treatment in patients with schizophrenia]. Alagille M; Blondiaux I; Ginestet D Encephale; 1990; 16(2):125-31. PubMed ID: 1972052 [TBL] [Abstract][Full Text] [Related]
17. Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study. Kramer MS; Gorkin R; DiJohnson C Hillside J Clin Psychiatry; 1989; 11(2):107-19. PubMed ID: 2577308 [TBL] [Abstract][Full Text] [Related]
18. The use of high doses of neuroleptics: the current situation. King DJ Int Clin Psychopharmacol; 1994; 9(2):75-8. PubMed ID: 7914527 [No Abstract] [Full Text] [Related]
19. [Delayed-action neuroleptics and maintenance treatments]. Péron-Magnan P Encephale; 1991; 17(4):263-6. PubMed ID: 1683627 [TBL] [Abstract][Full Text] [Related]
20. [Changes in the health state of schizophrenic patients in neuroleptic therapy]. Heim M Psychiatr Neurol Med Psychol (Leipz); 1986 Aug; 38(8):483-7. PubMed ID: 2878452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]